Cargando…
Effectiveness and tolerability of lacosamide in children with drug resistant epilepsy
We retrospectively studied the efficacy and tolerability of lacosamide (LCM) in children with drug-resistant epilepsy in a tertiary care centre in the Netherlands, from 2013 till 2019, with a follow-up of two years. 79 children, aged < 18 years, were included. Retention rate, effectiveness, reaso...
Autores principales: | Driessen, J.T., Wammes–van der Heijden, E.A., Verschuure, P., Fasen, K.C.F.M., Teunissen, M.W.A., Majoie, H.J.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762192/ https://www.ncbi.nlm.nih.gov/pubmed/36545476 http://dx.doi.org/10.1016/j.ebr.2022.100574 |
Ejemplares similares
-
Ventricular tachycardia associated with lacosamide co-medication in drug-resistant epilepsy()
por: DeGiorgio, Andrew C., et al.
Publicado: (2012) -
Unmasking of myoclonus by lacosamide in generalized epilepsy
por: Birnbaum, Daniel, et al.
Publicado: (2016) -
Safety and Tolerability of Lacosamide in Patients With Epilepsy: A Systematic Review and Meta-Analysis
por: Yang, Chunsong, et al.
Publicado: (2021) -
Safety of lacosamide in children with refractory partial epilepsy
por: Pasha, Ismail, et al.
Publicado: (2015) -
The effect of lacosamide on psychiatric comorbidities in patients with epilepsy
por: Hasegawa, Naoya, et al.
Publicado: (2020)